Circio Holding ASA (OSL:CRNA)

Norway flag Norway · Delayed Price · Currency is NOK
0.6500
+0.0100 (1.56%)
At close: Apr 16, 2025
-75.75%
Market Cap 57.39M
Revenue (ttm) n/a
Net Income (ttm) 57.52M
Shares Out 84.14M
EPS (ttm) 2.79
PE Ratio 0.24
Forward PE 1.07
Dividend n/a
Ex-Dividend Date n/a
Volume 530,651
Average Volume 1,320,016
Open 0.6600
Previous Close 0.6400
Day's Range 0.6000 - 0.6600
52-Week Range 0.5400 - 13.2000
Beta 1.67
RSI 63.15
Earnings Date Apr 10, 2025

About Circio Holding ASA

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a collaboration with Certest Biotec, S.L. for formulation of circVec into lipid nanoparticles. The company was formerly known as Targovax ASA and changed... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 10
Stock Exchange Oslo Børs
Ticker Symbol CRNA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.